BPMC logo

Blueprint Medicines (BPMC) Short Term Debt

Annual Short Term Debt

$42.21 M
+$14.78 M+53.89%

December 31, 2023


Summary


Performance

BPMC Short Term Debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherBPMCbalance sheetmetrics:

Quarterly Short Term Debt

$58.04 M
-$2.87 M-4.72%

September 30, 2024


Summary


Performance

BPMC Quarterly Short Term Debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherBPMCbalance sheetmetrics:

Short Term Debt Formula

Short-Term Debt = Current Portion of Long-Term Debt + Short-Term Loans + Commercial Paper + Other Short-Term Borrowings

BPMC Short Term Debt Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+53.9%+38.7%
3 y3 years+432.0%+99.1%
5 y5 years+2362.7%+99.1%

BPMC Short Term Debt Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+421.6%-4.7%+617.2%
5 y5-yearat high+518.7%-4.7%+750.7%
alltimeall timeat high+5862.0%-4.7%+3306.3%

Blueprint Medicines Short Term Debt History

DateAnnualQuarterly
Sep 2024
-
$58.04 M(-4.7%)
Jun 2024
-
$60.92 M(+43.6%)
Mar 2024
-
$42.42 M(+0.5%)
Dec 2023
$42.21 M(+53.9%)
$42.21 M(+0.9%)
Sep 2023
-
$41.84 M(+43.5%)
Jun 2023
-
$29.15 M(+3.1%)
Mar 2023
-
$28.27 M(+3.1%)
Dec 2022
$27.43 M(+238.9%)
$27.43 M(+8.0%)
Sep 2022
-
$25.41 M(+169.3%)
Jun 2022
-
$9.44 M(+7.7%)
Mar 2022
-
$8.76 M(+8.3%)
Dec 2021
$8.09 M(+2.0%)
$8.09 M(-8.1%)
Sep 2021
-
$8.81 M(+4.1%)
Jun 2021
-
$8.46 M(+3.3%)
Mar 2021
-
$8.19 M(+3.3%)
Dec 2020
$7.93 M(+16.3%)
$7.93 M(+3.4%)
Sep 2020
-
$7.67 M(+3.5%)
Jun 2020
-
$7.42 M(+3.4%)
Mar 2020
-
$7.17 M(+5.1%)
Dec 2019
$6.82 M
$6.82 M(+3.6%)
DateAnnualQuarterly
Sep 2019
-
$6.59 M(+3.6%)
Jun 2019
-
$6.36 M(+20.4%)
Mar 2019
-
$5.28 M(+207.9%)
Dec 2018
$1.71 M(-47.0%)
$1.71 M(-13.9%)
Sep 2018
-
$1.99 M(-17.2%)
Jun 2018
-
$2.41 M(-14.7%)
Mar 2018
-
$2.82 M(-12.7%)
Dec 2017
$3.23 M(+3.3%)
$3.23 M(-8.5%)
Sep 2017
-
$3.53 M(-4.4%)
Jun 2017
-
$3.69 M(+35.9%)
Mar 2017
-
$2.72 M(-13.1%)
Dec 2016
$3.13 M(-18.6%)
$3.13 M(-7.2%)
Sep 2016
-
$3.37 M(-6.7%)
Jun 2016
-
$3.61 M(-6.2%)
Mar 2016
-
$3.85 M(+0.2%)
Dec 2015
$3.84 M(+125.6%)
$3.84 M(+8.1%)
Sep 2015
-
$3.56 M(+13.6%)
Jun 2015
-
$3.13 M(+47.2%)
Mar 2015
-
$2.13 M(+24.8%)
Dec 2014
$1.70 M(+140.7%)
$1.70 M
Dec 2013
$708.00 K
-

FAQ

  • What is Blueprint Medicines annual short term debt?
  • What is the all time high annual short term debt for Blueprint Medicines?
  • What is Blueprint Medicines annual short term debt year-on-year change?
  • What is Blueprint Medicines quarterly short term debt?
  • What is the all time high quarterly short term debt for Blueprint Medicines?
  • What is Blueprint Medicines quarterly short term debt year-on-year change?

What is Blueprint Medicines annual short term debt?

The current annual short term debt of BPMC is $42.21 M

What is the all time high annual short term debt for Blueprint Medicines?

Blueprint Medicines all-time high annual short term debt is $42.21 M

What is Blueprint Medicines annual short term debt year-on-year change?

Over the past year, BPMC annual short term debt has changed by +$14.78 M (+53.89%)

What is Blueprint Medicines quarterly short term debt?

The current quarterly short term debt of BPMC is $58.04 M

What is the all time high quarterly short term debt for Blueprint Medicines?

Blueprint Medicines all-time high quarterly short term debt is $60.92 M

What is Blueprint Medicines quarterly short term debt year-on-year change?

Over the past year, BPMC quarterly short term debt has changed by +$16.20 M (+38.73%)